Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Clinical trial NCT01776424 · COMPLETED
Trial details
- NCT number
- NCT01776424
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-28
- Primary completion
- 2017-07-21
- Enrollment
- 27395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.